Explore
Validate
LearnABIN565503
antibody from antibodies-online
Targeting: F11R
CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN565503 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-F11 Receptor (F11R) (AA 1-299), (full length) antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-299, full length
- Isotype
- IgG
- Antibody clone number
- 2E3-1C8
- Vial size
- 100 μg
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Handling
- Aliquot to avoid repeated freezing and thawing.
Submitted references Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
JAM-A expression positively correlates with poor prognosis in breast cancer patients.
Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma.
Huang JY, Xu YY, Sun Z, Wang ZN, Zhu Z, Song YX, Luo Y, Zhang X, Xu HM
The Journal of surgical research 2014 Dec;192(2):494-502
The Journal of surgical research 2014 Dec;192(2):494-502
Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
Fong D, Spizzo G, Mitterer M, Seeber A, Steurer M, Gastl G, Brosch I, Moser P
Annals of surgical oncology 2012 Dec;19(13):4330-6
Annals of surgical oncology 2012 Dec;19(13):4330-6
JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM
International journal of cancer 2009 Sep 15;125(6):1343-51
International journal of cancer 2009 Sep 15;125(6):1343-51
Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma.
Gutwein P, Schramme A, Voss B, Abdel-Bakky MS, Doberstein K, Ludwig A, Altevogt P, Hansmann ML, Moch H, Kristiansen G, Pfeilschifter J
Biochemical and biophysical research communications 2009 Mar 6;380(2):387-91
Biochemical and biophysical research communications 2009 Mar 6;380(2):387-91
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
